GCP
IMMU

GSA Capital Partners’s Immunomedics Inc IMMU Stock Holding History

GSA Capital Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,568
Closed -$308K – 1757
2019
Q4 		$308K Buy
+14,568
New +$257K 0.04% 1008
2019
Q3 		– Sell
-21,200
Closed -$294K – 1860
2019
Q2 		$294K Buy
+21,200
New +$319K 0.03% 1019
2014
Q1 		– Sell
-13,419
Closed -$62K – 1890
2013
Q4 		$62K Sell
13,419
-45,119
-77% -$201K ﹤0.01% 1592
2013
Q3 		$362K Sell
58,538
-211,952
-78% -$1.22M 0.03% 1011
2013
Q2 		$1.47M Buy
+270,490
New +$888K 0.17% 117

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GSA Capital Partners's IMMU Position: Q1 2020 in Review

GSA Capital Partners sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 14,568 shares — an estimated $308K sold.

GSA Capital Partners first reported a position in IMMU in Q2 2013 and held it in 5 quarters. The position peaked at $1.47M in Q2 2013. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • GSA Capital Partners reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • GSA Capital Partners sold 14,568 Immunomedics Inc shares in Q1 2020, an estimated $308K.
  • GSA Capital Partners first reported a position in Immunomedics Inc in Q2 2013 and held it in 5 quarters.
  • GSA Capital Partners's Immunomedics Inc position peaked at $1.47M in Q2 2013.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on GSA Capital Partners's 13F filing for Q1 2020, filed 12 May 2020.